2007
DOI: 10.1007/bf03021717
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative management of aplastic anemia in pregnancy with platelet transfusion refractoriness

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“… 70 If PTR is detected in a pregnant patient who has received blood transfusions, then HLA- and/or HPA-compatible platelet transfusions are indicated. 71 …”
Section: Maternal and Fetal Considerations In Aplastic Anemia In Pregmentioning
confidence: 99%
“… 70 If PTR is detected in a pregnant patient who has received blood transfusions, then HLA- and/or HPA-compatible platelet transfusions are indicated. 71 …”
Section: Maternal and Fetal Considerations In Aplastic Anemia In Pregmentioning
confidence: 99%
“…7 According to one theory, a population of primitive CD34 progenitors responsible for cellular proliferation and regeneration is produced in maternal bone marrow in response to interaction with umbilical cord blood cells via immunologic signals. 8 Pregnancy is also sometimes accompanied by gestational thrombocytopenia and relative leukocytosis. The factors responsible for the observed thrombocytopenia in pregnant patients with aplastic anemia are yet to be defi nitively elucidated.…”
Section: Introductionmentioning
confidence: 99%